← Leaderboards
Amy F.t. Arnsten
Yale University
$29,779,079
Attributed
$33,991,076
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,033,476 · 17
By mechanism
R01$18,420,695 · 6
P01$13,448,950 · 4
DP1$4,137,525 · 1
R37$2,951,446 · 1
RL1$1,753,500 · 1
T32$1,040,670 · 1
Top collaborators
- Barbara Stauch Slusher5 shared
- Takashi Tsukamoto5 shared
- Daeyeol Lee4 shared
- Steve W. C. Chang1 shared
- Monika P. Jadi1 shared
- Anirvan S. Nandy1 shared
Most similar at Yale University
Same institution · by research overlap
- Yung-Chi Cheng$16,454,542
- Yann Sebastien Mineur$794,625
- Jonathan E Ploski$2,994,912
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsSignal TransductionCognitive FunctionMonkeysCyclic AmpShort-Term MemoryCognitivePrefrontal CortexMolecularPharmaceutical PreparationsCognitionAgingBrainAgedAnimalsMemoryDoseBaseImpaired CognitionRattusPrimatesElderlyPotassium ChannelRegulation
Grant awards (82)
Prefrontal impairment with stress- NE receptor subtype mechanisms.$802,395
R01 · FY2025 · MH · contact PI
Toward developing a navigation model of the aging brain in the marmoset$461,146
R21 · FY2025 · AG
Prefrontal impairment with stress- NE receptor subtype mechanisms.$819,234
R01 · FY2024 · MH · contact PI
Development of GCPII inhibitors for the treatment of age-related cognitive disorders$784,969
R01 · FY2024 · AG
Prefrontal impairment with stress- NE receptor subtype mechanisms.$836,264
R01 · FY2023 · MH · contact PI
Development of GCPII inhibitors for the treatment of age-related cognitive disorders$784,616
R01 · FY2023 · AG
Preclinical assessment of GCPII inhibitors for cognition and tau pathology$601,131
R01 · FY2023 · AG · contact PI
Development of GCPII inhibitors for the treatment of age-related cognitive disorders$828,290
R01 · FY2022 · AG
Preclinical assessment of GCPII inhibitors for cognition and tau pathology$753,346
R01 · FY2022 · AG · contact PI
Preclinical assessment of GCPII inhibitors for cognition and tau pathology$415,871
R01 · FY2022 · AG · contact PI
Preclinical assessment of GCPII inhibitors for cognition and tau pathology$779,486
R01 · FY2021 · AG · contact PI
Development of GCPII inhibitors for the treatment of age-related cognitive disorders$704,994
R01 · FY2021 · AG
Preclinical assessment of GCPII inhibitors for cognition and tau pathology$811,824
R01 · FY2020 · AG · contact PI
Development of GCPII inhibitors for the treatment of age-related cognitive disorders$720,931
R01 · FY2020 · AG
Rapid actions of ketamine in the prefrontal cortex$652,880
R01 · FY2020 · MH · contact PI
Preclinical assessment of GCPII inhibitors for cognition and tau pathology$810,149
R01 · FY2019 · AG · contact PI
Rapid actions of ketamine in the prefrontal cortex$652,880
R01 · FY2019 · MH · contact PI
Rapid actions of ketamine in the prefrontal cortex$704,512
R01 · FY2018 · MH
Highly evolved brain circuits in primates: molecular vulnerabilities for disease$832,500
DP1 · FY2017 · AG · contact PI
Rapid actions of ketamine in the prefrontal cortex$638,002
R01 · FY2017 · MH
Potential mGluR treatment of age-related cognitive decline$599,167
R01 · FY2017 · AG · contact PI
Highly evolved brain circuits in primates: molecular vulnerabilities for disease$832,500
DP1 · FY2016 · AG · contact PI
Rapid actions of ketamine in the prefrontal cortex$638,482
R01 · FY2016 · MH
Potential mGluR treatment of age-related cognitive decline$619,646
R01 · FY2016 · AG · contact PI
mGluR2/3 influences in primate prefrontal cortex: potential for therapeutics$499,500
R01 · FY2016 · MH · contact PI
Highly evolved brain circuits in primates: molecular vulnerabilities for disease$807,525
DP1 · FY2015 · AG · contact PI
Potential mGluR treatment of age-related cognitive decline$622,841
R01 · FY2015 · AG · contact PI
mGluR2/3 influences in primate prefrontal cortex: potential for therapeutics$499,500
R01 · FY2015 · MH · contact PI
Highly evolved brain circuits in primates: molecular vulnerabilities for disease$832,500
DP1 · FY2014 · AG · contact PI
Potential mGluR treatment of age-related cognitive decline$662,357
R01 · FY2014 · AG · contact PI
mGluR2/3 influences in primate prefrontal cortex: potential for therapeutics$499,500
R01 · FY2014 · MH · contact PI
Highly evolved brain circuits in primates: molecular vulnerabilities for disease$832,500
DP1 · FY2013 · AG · contact PI
Potential mGluR treatment of age-related cognitive decline$677,928
R01 · FY2013 · AG · contact PI
Molecular and Cellular Basis of Cognitive Aging in Prefrontal Cortical Networks$1,254,518
P01 · FY2012 · AG · contact PI
ANIMAL CORE$354,986
P01 · FY2012 · AG · contact PI
PHARMACOLOGICAL PROTECTION OF AGING PREFRONTAL CORTICAL NETWORKS$175,573
P01 · FY2012 · AG · contact PI
ADMINISTRATIVE CORE$107,355
P01 · FY2012 · AG · contact PI
Molecular and Cellular Basis of Cognitive Aging in Prefrontal Cortical Networks$2,279,245
P01 · FY2011 · AG · contact PI
ANIMAL CORE$621,878
P01 · FY2011 · AG · contact PI
Ionic and Second Messanger Basis of Stress-Induced Prefrontal Dysfunction (#2 of$318,249
RL1 · FY2011 · AA · contact PI
PHARMACOLOGICAL PROTECTION OF AGING PREFRONTAL CORTICAL NETWORKS$302,296
P01 · FY2011 · AG · contact PI
ADMINISTRATIVE CORE$196,362
P01 · FY2011 · AG · contact PI
Molecular and Cellular Basis of Cognitive Aging in Prefrontal Cortical Networks$1,799,830
P01 · FY2010 · AG · contact PI
ANIMAL CORE$490,360
P01 · FY2010 · AG · contact PI
Ionic and Second Messanger Basis of Stress-Induced Prefrontal Dysfunction (#2 of$321,464
RL1 · FY2010 · AA · contact PI
PHARMACOLOGICAL PROTECTION OF AGING PREFRONTAL CORTICAL NETWORKS$238,368
P01 · FY2010 · AG · contact PI
ADMINISTRATIVE CORE$154,830
P01 · FY2010 · AG · contact PI
Molecular and Cellular Basis of Cognitive Aging in Prefrontal Cortical Networks$1,778,742
P01 · FY2009 · AG · contact PI
ANIMAL CORE$521,334
P01 · FY2009 · AG · contact PI
Ionic and Second Messanger Basis of Stress-Induced Prefrontal Dysfunction (#2 of$324,711
RL1 · FY2009 · AA · contact PI
PHARMACOLOGICAL PROTECTION OF AGING PREFRONTAL CORTICAL NETWORKS$253,426
P01 · FY2009 · AG · contact PI
ADMINISTRATIVE CORE$164,608
P01 · FY2009 · AG · contact PI
Molecular and Cellular Basis of Cognitive Aging in Prefrontal Cortical Networks$149,617
P01 · FY2009 · AG · contact PI
Ionic and Second Messanger Basis of Stress-Induced Prefrontal Dysfunction (#2 of$134,365
RL1 · FY2009 · AA · contact PI
Molecular and Cellular Basis of Cognitive Aging in Prefrontal Cortical Networks$1,780,448
P01 · FY2008 · AG · contact PI
ANIMAL CORE$478,710
P01 · FY2008 · AG · contact PI
Ionic and Second Messanger Basis of Stress-Induced Prefrontal Dysfunction (#2 of$324,711
RL1 · FY2008 · AA · contact PI
Neurobiology of cortical Systems.$189,351
T32 · FY2008 · NS · contact PI
PHARMACOLOGICAL PROTECTION OF AGING PREFRONTAL CORTICAL NETWORKS$180,657
P01 · FY2008 · AG · contact PI
ADMINISTRATIVE CORE$165,807
P01 · FY2008 · AG · contact PI
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$365,530
R37 · FY2007 · AG · contact PI
Ionic and Second Messanger Basis of Stress-Induced Prefrontal Dysfunction$330,000
RL1 · FY2007 · AA · contact PI
Neurobiology of cortical Systems.$194,159
T32 · FY2007 · NS · contact PI
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$443,986
R37 · FY2006 · AG · contact PI
Neurobiology of cortical Systems.$122,129
T32 · FY2006 · NS · contact PI
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$49,017
R37 · FY2006 · AG · contact PI
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$5,000
R37 · FY2006 · AG · contact PI
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$363,379
R37 · FY2005 · AG
Intracellular signaling mechanisms and D1 modulation$196,200
P50 · FY2005 · MH
Neurobiology of cortical Systems.$194,159
T32 · FY2005 · NS
Estrogen, Stress and Dysfunction of Prefrontal Cortex$194,156
R21 · FY2005 · MH
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$400,536
R37 · FY2004 · AG
Estrogen, Stress and Dysfunction of Prefrontal Cortex$232,988
R21 · FY2004 · MH
Intracellular signaling mechanisms and D1 modulation$196,200
P50 · FY2004 · MH
NEUROBIOLOGY OF CORTICAL SYSTEMS$118,930
T32 · FY2004 · NS
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$342,519
R37 · FY2003 · AG
NEUROBIOLOGY OF CORTICAL SYSTEMS$221,942
T32 · FY2003 · NS
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$44,145
R37 · FY2003 · AG
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$21,013
R37 · FY2003 · AG
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$312,144
R37 · FY2002 · AG
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$307,982
R37 · FY2001 · AG
COGNITIVE LOSS WITH AGE--ROLE OF CORTICAL CATECHOLAMINES$296,195
R37 · FY2000 · AG